Glycodesign Inc.
Records under this name other than patents Glycodesign Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,395,745 | Alkaloid halide salts of swainsonine and methods of use Term ended Term ended Mar 27, 2020 · From the USPTO record | Term ended | Term ended Mar 27, 2020 | From the USPTO record |
| US 6,051,711 | Synthesis of swainsonine salts Lapsed on the fee record Ended Apr 18, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2012 | From the USPTO record |
| US 6,048,870 | 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents Lapsed on the fee record Ended Apr 11, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 11, 2012 | From the USPTO record |
| US 6,593,119 | Core 2 &bgr;-1,6-N-acetylglycosaminyltransferase gene Lapsed on the fee record Ended Jul 15, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2011 | From the USPTO record |
| US 6,415,234 | Designing inhibitors for glycosyltransferases Lapsed on the fee record Ended Jul 2, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2010 | From the USPTO record |
| US 6,897,052 | N-acetylglycosaminyl transferase genes Lapsed on the fee record Ended May 24, 2009 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2009 | From the USPTO record |
| US 5,187,279 | Synthesis of (-) swainsonine and intermediate compounds employed in such synthesis Term ended Term ended no later than Feb 16, 2013 · Low confidence | Term ended | Term ended no later than Feb 16, 2013 | Low confidence |
| US 5,288,875 | Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis Term ended Term ended no later than Feb 22, 2014 · Low confidence | Term ended | Term ended no later than Feb 22, 2014 | Low confidence |
| US 5,484,925 | Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis Term ended Term ended no later than Jan 16, 2016 · Low confidence | Term ended | Term ended no later than Jan 16, 2016 | Low confidence |
| US 5,650,413 | Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents Term ended Term ended no later than Jul 22, 2017 · Low confidence | Term ended | Term ended no later than Jul 22, 2017 | Low confidence |